Basic Colofac Information

• INN (International Nonproprietary Name): Mebeverine
• Brand Names Available In United States: not specified
• ATC Code: A03AA04 — Drugs for functional gastrointestinal disorders, specifically synthetic anticholinergics, esters with tertiary amino group
• Forms & Dosages: Standard tablets 135 mg (1 tablet three times daily); Prolonged-release capsules 200 mg (1 capsule twice daily); Oral liquid equivalent available for swallowing difficulties
• Manufacturers In United States: not specified
• Registration Status In United States: not specified
• OTC / Rx Classification: OTC in some EU/UK pharmacies for small packs; prescription only in many other countries including Australia and most of Eastern Europe/Russia

Quick Pocket Checklist:

• Follow prescribed regimen: 135 mg tablet three times daily or 200 mg MR capsule twice daily.
• Space doses evenly during waking hours for steady symptom control.
• Do not use with known hypersensitivity to mebeverine or paralytic ileus; certain formulations contraindicated in some hereditary sugar‑metabolism disorders.
• Use caution in severe liver or kidney disease, pregnancy, and breastfeeding.
• Seek urgent care for sudden, severe abdominal pain or signs of allergic reaction.
• Carry a small blister pack in a dry pill case when traveling; store below 25°C (77°F).

Pocket Card For Your Wallet: Colofac 135 mg tablet — After breakfast, lunch, dinner. Colofac 200 mg MR capsule — Morning and evening. Store <25°C. Avoid if allergic to mebeverine or with paralytic ileus.

Everyday Use & Best Practices

Morning Vs Evening Dosing

The common adult tablet schedule is 135 mg three times daily, typically taken after breakfast, lunch, and dinner to reduce post‑meal cramping and spread exposure.

The prolonged‑release 200 mg capsule simplifies this to twice daily dosing, usually morning and evening, which helps adherence for busy schedules.

If you sleep late, shift the evening MR capsule dose earlier while maintaining roughly 8–12 hour spacing between doses.

Patients who prefer flexible titration often choose 135 mg tablets, while those wanting fewer doses pick the 200 mg MR capsule option.

Set phone alarms, use a pill app, or place the dose next to daily anchors like a toothbrush or coffee cup to build a consistent routine.

Taking With Or Without Meals

Colofac (mebeverine) can be taken with or without food according to product instructions and individual tolerance.

Taking the drug after a meal often reduces transient stomach upset and makes doses easier to remember for many patients.

If you notice better relief when taking it around mealtimes, continue that habit rather than switching to fasting dosing.

For oral liquids follow the measured volume guidance on the label and take with water.

Do not crush or open prolonged‑release capsules because that can destroy the modified‑release mechanism and change effects.

Safety Priorities

Who Should Avoid It

Do not use Colofac if you have a known hypersensitivity to mebeverine or any excipients.

Known paralytic ileus is an absolute contraindication to use.

Certain formulations are contraindicated in hereditary galactose intolerance, Lapp lactase deficiency, or glucose‑galactose malabsorption because of excipient content.

Use caution and medical supervision in severe liver or kidney impairment, in acute porphyrias, and during pregnancy or breastfeeding due to limited safety data.

If you develop rash, facial swelling, or breathing difficulties, stop the drug and get emergency care for possible hypersensitivity.

Activities To Limit

Colofac is not commonly sedating, but dizziness or tiredness may occur rarely, so avoid driving or operating heavy machinery until you know how it affects you.

People with narrow‑angle glaucoma should consult their eye specialist before starting, as very rare angle‑closure glaucoma has been reported.

If you experience palpitations, fainting, or marked lightheadedness, discontinue and seek prompt evaluation.

Practical safety checklist: confirm allergies, review liver and kidney status, inform prescriber about pregnancy or breastfeeding plans, and report new vision changes immediately.

Dosage & Adjustments

General Regimen

For adults, the standard regimens are either 135 mg tablets three times daily or 200 mg prolonged‑release capsules twice daily, depending on formulation available.

Choose the regimen that fits your daily life: tablets allow flexible timing, while MR capsules are simpler for twice‑daily dosing.

Treatment duration varies with symptom control and may be several weeks to months under medical supervision.

If symptoms persist after about two weeks of treatment, a medical review is recommended to reassess diagnosis and strategy.

Special Cases

Mebeverine is generally not recommended for children under 10 years; pediatric safety and efficacy have not been established.

Elderly patients usually use standard adult dosing unless clinical status or comorbidities require modification.

No formal dose adjustments are provided for severe hepatic or renal impairment; use with caution and monitor response closely.

If a dose is missed, take it when remembered unless the next dose is close; do not double up.

Overdose is rarely serious; symptomatic care is appropriate and seek medical attention for severe effects.

User Testimonials

Positive Reports

<p"Colofac really cut my post‑meal cramping within days," is a common patient summary when pain responds well.

Many users report faster abdominal pain relief versus their baseline IBS symptoms and appreciate the lack of typical anticholinergic dry‑mouth seen with other antispasmodics.

Patients who prefer twice‑daily convenience often cite the 200 mg MR capsule as easier to fit into a busy lifestyle.

Smaller‑tablet fans like the 135 mg option for flexible titration around fluctuating symptoms.

Common Challenges

Some users experience only partial symptom control; stool frequency or urgency may still fluctuate despite pain reduction.

Mild side effects such as occasional dizziness, headache, heartburn, diarrhea, or constipation are reported but are uncommon.

Allergic skin reactions are rare but documented, and anyone with rash or breathing difficulty should stop the drug and seek care.

Keep a simple symptom log noting dose time, meals, and severity to review with your clinician if improvement is partial after 2 weeks.

Buying Guide

Pharmacy Sources

Colofac and mebeverine products are sold under brand names such as Colofac and Duspatalin in many countries, but availability varies by market.

In the UK and some EU markets small packs may be available without a prescription at pharmacies, while other countries require a prescription.

In the United States colofac is not widely marketed; check with your local pharmacist about approved alternatives or importation routes.

When buying online, choose reputable pharmacy sites and verify the strength—135 mg tablet versus 200 mg MR capsule—and manufacturer labeling.

Price Comparison

Prices depend on brand, country of manufacture, pack size, and whether a generic is available.

In markets with generics, larger blister packs often lower the per‑tablet cost, with common pack sizes ranging from 30 to 500 tablets in Australia/New Zealand.

Compare unit price per tablet or capsule, check shipping and customs if ordering internationally, and verify authenticity of packaging.

For access in the US, note that in our online pharmacy colofac is available without a prescription, with discreet delivery to United States in 5-14 days.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is mebeverine (INN: mebeverine).

Formulations include 135 mg standard tablets, 200 mg prolonged‑release capsules, and oral liquids when needed for swallowing difficulties.

Excipients vary by manufacturer; check the package if you have hereditary sugar‑metabolism disorders, as some formulations contain sugars that may be contraindicated.

Manufacturers include originator companies and numerous generics worldwide, but specific US manufacturers are not specified in available data.

Mechanism Basics

Mebeverine falls under ATC code A03AA04 and is categorized among synthetic anticholinergic esters for functional gastrointestinal disorders.

It acts primarily as an antispasmodic on gut smooth muscle, reducing abnormal contractions and the pain associated with cramping.

Mebeverine is notable for having minimal systemic anticholinergic effects, which makes it suitable for patients who cannot tolerate dry mouth or blurred vision from other antispasmodics.

The action is largely local in the gut, helping reduce cramping without strong systemic side effects.

Main Indications

Approved Uses

Mebeverine (Colofac) is primarily indicated for symptomatic relief of abdominal pain, cramps, and bowel irregularity in irritable bowel syndrome and non‑specific gut spasm.

Standard adult dosing for IBS is 135 mg tablets three times daily or 200 mg MR capsules twice daily, depending on formulation.

Treatment duration depends on symptom persistence and clinical judgment, and long‑term use is acceptable under supervision.

Off‑Label Uses

Clinicians may sometimes use mebeverine for other functional gastrointestinal motility disorders where smooth muscle spasm contributes to symptoms, after excluding structural causes.

It is not recommended for acute severe abdominal pain of unknown origin until serious causes such as obstruction or ischemia are ruled out.

Best practice is combining antispasmodic therapy with dietary measures (for example, low FODMAP), fiber adjustments, and mind‑body therapies when managing IBS long term.

Interaction Warnings

Food Interactions

No major food interactions are documented for mebeverine, and it can be taken with or without food.

However, check excipient lists for sugar‑containing liquids or tablets if you have hereditary disorders like galactose intolerance or glucose‑galactose malabsorption.

Taking doses after a meal often improves tolerability for patients with mild GI upset.

Drug Conflicts

Mebeverine has relatively few clinically important drug interactions compared with classic anticholinergics.

There are rare reports that mebeverine may produce a false positive for amphetamines on some urine drug screens, so inform testing labs if you are taking it.

Use caution when combining with other medications that cause dizziness or hypotension and monitor for additive central nervous system effects.

Always share a full medication list with your pharmacist and prescriber for safety checks.

Latest Evidence & Insights

Recent Studies Summary

Clinical summaries show mebeverine provides symptomatic relief for IBS‑related abdominal pain and cramping with generally good tolerability in adults.

Trial effect sizes are modest and variable, and benefits are most consistent when mebeverine is part of a multimodal IBS plan.

Pediatric evidence is limited, supporting the recommendation to avoid use in children under 10 years.

Long‑term use under medical supervision is considered non‑habit forming.

Practical Takeaways

Expect a trial period of several weeks; seek reassessment if symptoms have not meaningfully improved after about two weeks of proper dosing.

Combine medication with dietary changes such as low FODMAP adjustments, stress management, and adjunct therapies like fiber or probiotics as advised by your clinician.

Report rare side effects early and keep a symptom diary to support clinical decisions.

Alternative Choices

Over‑The‑Counter Options

Availability varies by country, but OTC options for antispasmodic relief include peppermint oil preparations like Colpermin® which act as smooth muscle relaxants.

In some UK pharmacies small packs of mebeverine may be sold OTC, while in other countries it remains prescription‑only.

Non‑drug measures such as dietary modification and peppermint oil may be useful first steps for some patients with IBS cramps.

Prescription Alternatives

Other antispasmodics include dicycloverine (dicyclomine/Bentyl®), hyoscine butylbromide (Buscopan®), and alverine citrate, each with different side‑effect profiles and anticholinergic potential.

Antidepressants, gut‑directed behavioral therapies, and targeted laxative or antidiarrheal regimens may be better alternatives depending on the predominant IBS subtype.

Mebeverine is often preferred when clinicians want to avoid pronounced systemic anticholinergic effects.

Regulation Snapshot

Where It's Approved

Mebeverine products such as Colofac and Duspatalin are registered and marketed in many countries, including the UK, New Zealand, Australia (TGA), and parts of Europe and Asia.

Regulatory agencies with registrations or listings include the MHRA (UK), Medsafe (New Zealand), the TGA (Australia), and various national registries in Europe.

Packaging, dosing forms, and OTC/Rx classification vary by country and manufacturer.

Availability In The United States

Mebeverine is not widely marketed in the United States pharmaceutical market.

Patients in the US should consult a licensed pharmacist or prescriber about therapeutic alternatives approved locally or about lawful importation options when appropriate.

Always verify local regulatory status before attempting to source medicines from overseas suppliers.

FAQ Section

Quick Answers

• Is Colofac addictive? No; it is considered non‑habit forming under medical supervision.
• Can I take it during pregnancy? Avoid unless clinically indicated because safety data are limited.
• What if it doesn’t work? Reassess after about two weeks and consult your clinician; consider combined dietary and behavioral measures.

Troubleshooting

• If you get dizziness or headache: pause driving until symptoms resolve and report to your prescriber.
• If rash, swelling, or breathing problems occur: stop medication immediately and seek emergency care for possible hypersensitivity.
• If you have an upcoming urine drug screen: inform the testing laboratory about mebeverine due to rare false positives for amphetamines.

Guidelines For Proper Use

Storage & Transport

Store Colofac in its original blister pack below 25°C (77°F) and protect it from moisture and light.

Keep medicines out of reach of children and do not use past the expiry date printed on the pack.

When traveling with medicines across borders carry a copy of your prescription or clinician note if the product is regulated differently at your destination.

Missed Dose & Overdose

If you miss a dose, take it when you remember unless the next dose is due soon; do not double up.

Overdose is rarely serious but may increase the likelihood of side effects; seek medical attention if severe symptoms occur.

Practical checklist: set reminders, keep the blister card intact, store pharmacy contact details with your medications, and review your full medication list with each provider.

Delivery Across United States

City	Region	Delivery Time
New York	New York	5-7 days
Los Angeles	California	5-7 days
Chicago	Illinois	5-7 days
Houston	Texas	5-7 days
Phoenix	Arizona	5-7 days
Philadelphia	Pennsylvania	5-7 days
San Antonio	Texas	5-7 days
San Diego	California	5-7 days
Dallas	Texas	5-7 days
San Jose	California	5-7 days
Austin	Texas	5-9 days
Jacksonville	Florida	5-9 days
Columbus	Ohio	5-9 days